Clinical Trial Update: Aveir DR i2i Study [NA]

View source ↗

Summary

Abbott's Aveir DR i2i study for an artificial cardiac pacemaker shows posted results; the trial remains active but not recruiting as of the latest update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia
• Cardiac Arrhythmia

Drugs mentioned

• Aveir DR i2i

Snippet

Sponsor: Abbott Medical Devices | Conditions: Cardiac Pacemaker, Artificial, Cardiac Rhythm Disorder | NA | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-11-05